Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy;Exposition aux antidépresseurs inhibiteurs de la recapture de la sérotonine (IRS) en fin de grossesse: Retentissement néonatal

Archives de Pediatrie

Volumn 12, Issue 7, 2005, Pages 1081-1084

  Cissoko, H ^a   Swortfiguer, D ^a   Giraudeau, B ^a   Jonville Bera A P ^a   Autret Leca, E ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Adverse effects; Infant; Newborn; Pregnancy; Serotonin uptake inhibitors

Indexed keywords

BENZODIAZEPINE; CITALOPRAM; FLUOXETINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; MEPROBAMATE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TROPATEPINE; VENLAFAXINE;

ADULT; AGITATION; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; DELIVERY; FEMALE; HOSPITALIZATION; HUMAN; HYPONATREMIA; IRRITABILITY; MUSCLE HYPOTONIA; NEWBORN PERIOD; PREGNANCY; PREMATURITY; SHIVERING; SIDE EFFECT; UNCERTAINTY; WITHDRAWAL SYNDROME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MEDICAL RECORDS; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 20644451218     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.01.023     Document Type: Article

References (28)

1. A. Hostetter, J.C. Ritchie, and Z.N. Stowe Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women Biol Psychiatry 48 2000 1032 1034
2. A. Ericson, B. Källen, and B. Wiholm Delivery outcome after the use of antidepressants in early pregnancy Eur J Clin Pharmacol 55 1999 503 508
3. N.A. Kulin, A. Pastuszak, S.R. Sage, B. Schick-Boschetto, G. Spivey, and M. Feldkamp Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study JAMA 279 1998 609 610
4. C.D. Chambers, K.A. Johnson, L.M. Dick, R.J. Felix, and K.L. Jones Birth outcomes in pregnant women taking fluox́tine N Engl J Med 335 1996 1010 1015
5. H. Nordeng, R. Lindemann, K.V. Perminov, and A. Reikvam Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors Acta Paediatr 90 2001 288 291
6. J.A. Stiskal, N. Kulin, G. Koren, T. Ho, and S. Ito Neonatal paroxetine withdrawal syndrome Arch Dis Child Fetal Neonatal Ed 84 2001 F134 F135
7. A.M. Costei, E. Kozer, T. Ho, S. Ito, and G. Koren Perinatal outcome following third trimester exposure to paroxetine Arch Pediatr Adolesc Med 156 2002 1129 1132
8. K. Laine, T. Heikkinen, U. Ekblad, and P. Kero Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotoninergic symptoms in newborns and cord blood monoamine and prolactin concentrations Arch Gen Psychiatry 60 2003 720 726
9. S. Jaiswal, R.C. Coombs, and G.K. Isbister Paroxetine withdrawal in neonate with historical and laboratory confirmation Eur. J. Pediatr. 162 2003 723 724
10. N. Mamelle, F. Munoz, H. Grandjean pour le Groupe AUDIPOG Croissance foetale ̀ partir de l'́tude AUDIPOG 1. Etablissement de courbes de ŕf́rence J Gynecol Obstet Biol Reprod (Paris) 25 1996 61 70
11. J.S. Price, P.C. Waller, S.M. Wood, and A.V. Mackay A comparison of the postmarketing safety of four selective serotonin re-uptake inhibitors including investigation of symptoms occuring on withdrawal Br. J. Clin. Pharmacol. 42 1996 757 763
12. Canadian Medical Association Hyponatraemia and selective serotonin reuptake inhibitors Can. Med Assoc J 154 1996 63
13. A.J. Wagstaff, S.M. Cheer, A.J. Matheson, D. Ormrod, and K.L. Goa Paroxetine: an update of its use in psychiatric disorders in adults Drugs 62 2002 655 703
14. S.R. Grimsley, and M.W. Jann Paroxetine, sertraline and fluvoxamine: new selective serotonin reuptake inhibitors Clin. Pharm 11 1992 930 957
15. L.F. Gram Fluoxetine N Engl J Med 331 1994 1354 1361 Erratum 1995;332:343
16. D.J. Golstein Effects of third trimester fluoxetine exposure on the newborn J. Clin. Psychopharmacol. 15 1995 417 420
17. M.J. Spencer Fluoxetine hydrochloride (Prozac) toxicity in a neonate Pediatrics 92 1993 721 722
18. I.J. Nijhuis, G.W. Kok-van Rooij, and A.N. Bosschaart Withdrawal reactions of a premature neonate after maternal use of paroxetine Arch Dis Child Fetal Neonatal Ed 84 2001 F77
19. G.K. Isbister, A. Dawson, I.M. Whyte, F.H. Prior, C. Clancy, and A.J. Smith Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed. 85 2001 F147 F148
20. E. Elefant, F. Bavoux, C. Vauzelle-Gardier, M.P. Cournot, and F. Assari-Merabtene Psychotropes et grossesse J Gynecol Obstet Biol Reprod (Paris) 29 2000 43 51
21. B.M. Prenner Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride Am J Dis Child 131 1977 529 530
22. M. Berk, and B.F. Jacobson Selective serotonin reuptake inhibitor induced disturbances of haemostatis: mechanisms and therapeutic implications CNS Drugs 10 1998 441 446
23. C.P. Alderman, P. Seshadri, and D.I. Ben-Tovim Effects of serotonin reuptake inhibitors on hemostasis Ann Pharmacother 30 1996 1232 1234
24. Y.C. Duijvestijn, M.D. Kalmeijer, A.L. Passier, P. Dahlem, and F. Smiers Neonatal intraventricular haemorrhage associated with maternal use of paroxetine Br J Clin Pharmacol 56 2003 581 582
25. M.D. Salvia-Roiges, L. Garcia, A. Gonce-Mellgren, M.T. Esque-Ruiz, J. Figueras-Aloy, and X. Carbonell-Estrany Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine Rev Neurol 36 2003 724 726
26. D.L. Finfgeld SSRI-related hyponatremia among aging adults J Psychosoc Nurs Ment Health Serv 41 2003 12 16
27. M.A. Deeg, and E.W. Lipkin Hypoglycemia associated with the use of fluoxetine West J Med 164 1996 262 263
28. P.T. Pollak, S.D. Mukherjee, and A.D. Fraser Sertraline-induced hypoglycemia Ann Pharmacother 35 2001 1371 1374